Review Article
Regulation of MicroRNAs by Natural Agents: New Strategies in Cancer Therapies
Table 3
Selected miRNAs targeting tumour suppressor genes.
| Natural agent | miRNA | Regulation | Target(s) and function(s) | Cancer type | Reference |
| Curcumin | miR-186* | Down | Targets caspase-10; inhibits apoptosis | Lung | [46, 47] | miR-21 | Down | Targets PDCD4 | Colon | [48] |
| Resveratrol | miR-663 | Up | Targets TGFβ1 | Colon | [61] | miR-17-92, miR-10ab | Down | Targets PTEN | Prostate | [62] | miR-21 | Down | Targets PDCD4 and maspin | Prostate | [63, 64] |
| Genistein | miR-221, miR-222 | Down | Targets ARH1 | Prostate | [65] | miR-151 | Down | miRNA inhibition suppresses cell migration and invasion; targets N4BP1, CASZ1, IL1RAPL1, SOX17, and ARHGDIA | Prostate | [66] | miR-23b-3p | Down | Targets PTEN; miRNA inhibition induces apoptosis and inhibits invasion | Renal | [67] | miR-1260b | Down | Targets sFRP1, Dkk2 and, Smad4; induces cell proliferation and invasion; inhibits apoptosis | Renal; Prostate | [68, 69] | miR-223 | Down | Upregulates Fbw7; miRNA inhibition suppresses cell growth and induces apoptosis | Pancreatic | [70] | miR-27a | Down | Upregulates ZBTB10 and Sprouty2; miRNA inhibition suppresses cell growth, migration, and invasion and induces apoptosis | Melanoma; Ovarian; Pancreatic | [71–73] |
| EGCG | miR-98-5p | Down | miRNA inhibition enhances cisplatin-induced apoptosis and increases p53 expression | Lung | [74] |
| I3C | miR-21 | Down | Downregulates PTEN, PDCD4, and RECK | Lung; Pancreatic | [75, 76] | miR-221 | Down | Upregulates PTEN, p27kip1, p57kip2, and PUMA; increases cell proliferation | Pancreatic | [77] |
|
|